Skip to main content
OpenTrials
Completed

NCT Number: NCT05485662

Remineralization of Molar Incisor Hypomineralization (MIH) With a Hydroxyapatite Toothpaste

This study tests the remineralization of donor teeth (donorMIH) in situ in participants using 10% hydroxyapatite (HAP) toothpaste and sodium fluoride toothpaste.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–60 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

School of Dentistry, University of Texas Health Science Center

San Antonio, Texas, 78229, United States

About this study

Prior to each 2-week treatment phase, subjects will complete a 1-week washout period. Following the washout period, the intra-oral appliance containing a donorMIH tooth block will be fitted to each subject by a qualified dentist. Immediately after fitting of the first appliance (on day 1 of the first treatment phase), each subject will receive a soft bristled manual toothbrush for use throughout the duration of the study and a toothpaste according to the treatment phase. Subjects will be instructed to brush their teeth with the appliance in the mouth, two times daily, for 3 minutes on each brushing episode, in the morning after breakfast and last thing before bed, then rinsing with 10 ml of water. Over the study period, all subjects will maintain their normal dietary habits.

A 7-day washout period without an appliance will follow. After completion of the second washout period, subjects will return to the clinic, and the appliance, with another MIH-bearing tooth blocks mounted, will be fitted to the subject for the phase 2 treatment period. This procedure will then be repeated until the 2-week treatment phase is completed, and each subject has gone through the two arms of the study.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 18-60 years of age
  • Good general health
  • No known history of allergy to personal care/consumer products
  • Minimum of 20 natural uncrowned teeth (excluding third molars)
  • Normal salivary flow rate (stimulated and unstimulated flow of ≥0.7 ml/min and ≥0.2 ml/min respectively
  • Able to consent
  • Availability throughout entire study
  • Willing to wear intra-oral appliance 24 hours per day
  • Willing to use only assigned products for oral hygiene for duration of study

Exclusion criteria

  • Advanced periodontal disease
  • A medical condition that requires pre-medication prior to dental visits/procedures
  • Impaired salivary function
  • Orthodontic retainer(s)
  • Too few teeth to secure the oral appliance
  • Disease of the soft or hard oral tissues
  • Use of drugs that can affect salivary flow
  • Use of antibiotics one month prior to or during this study
  • Participation in another clinical study one week prior to the start of washout period or during this study period
  • Allergic hisotry to common toothpaste ingredients
  • Compromised immune system (HIV, AIDS, Immunosuppressive drug therapy)

Treatment and study plan

Hydroxyapatite toothpaste

Other

10% Hydroxyapatite toothpaste

Other names: HAP toothpaste

Sodium Fluoride Toothpaste

Other

1450 parts per million sodium fluoride toothpaste

Other names: NaF toothpaste

Primary outcomes

  1. Change in Mineral Density (MD) of Tooth

    Time frame: Baseline to 2 weeks

    Images will be collected from the samples to measure the mineral density before and after remineralization treatment. Total number of subjects enrolled in either the first allocation or the second allocation after the washout are included.

Sponsors and collaborators

Lead sponsor

The University of Texas Health Science Center at San Antonio

Other

Collaborators

  • Dr. Kurt Wolff GmbH & Co. KG

Registry information

Official study title

Remineralization of Molar Incisor Hypomineralization (MIH) With a Hydroxyapatite Toothpaste - an in Situ Study

Important dates

Study start
2022
Primary completion
2022
Study completion
2022
First posted
Aug 3, 2022
Registry last updated
Apr 12, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.